Hikma Pharmaceuticals USA Inc, a wholly owned subsidiary of Hikma Pharmaceuticals PLC has appointed Kristy Ronco as executive vice president, sales and marketing for its generics division.
Ronco will be responsible for leading Generics’ retail sales, addiction therapy sales and branded sales teams.
She will also oversee marketing, pricing, forecasting and analytics.
Ronco joins Hikma after 11 years at Zydus Pharmaceuticals where she was most recently senior vice president, sales and marketing. Earlier in her career, she held successive positions of increasing responsibility in marketing, contracts, pricing and market analysis at TEVA, Sandoz, Aventis and Johnson & Johnson. Ronco is also a registered nurse with extensive clinical patient-care experience across a range of medical disciplines and specialities.
Hikma Pharmaceuticals USA Inc, a wholly owned subsidiary of Hikma Pharmaceuticals PLC has appointed Kristy Ronco as executive vice president, sales and marketing for its generics division.
Ronco will be responsible for leading Generics’ retail sales, addiction therapy sales and branded sales teams.
She will also oversee marketing, pricing, forecasting and analytics.
Ronco joins Hikma after 11 years at Zydus Pharmaceuticals where she was most recently senior vice president, sales and marketing. Earlier in her career, she held successive positions of increasing responsibility in marketing, contracts, pricing and market analysis at TEVA, Sandoz, Aventis and Johnson & Johnson. Ronco is also a registered nurse with extensive clinical patient-care experience across a range of medical disciplines and specialities.
No comments:
Post a Comment